We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 09, 2020

Edoxaban in Atrial Fibrillation Patients With PCI by Acute or Chronic Coronary Syndrome Presentation

European Heart Journal


Additional Info

European Heart Journal
Edoxaban in Atrial Fibrillation Patients With Percutaneous Coronary Intervention by Acute or Chronic Coronary Syndrome Presentation: A Pre-Specified Analysis of the ENTRUST-AF PCI Trial
Eur Heart J 2020 Aug 29;[EPub Ahead of Print], P Vranckx, M Valgimigli, L Eckardt, T Lewalter, R Unikas, F Marin, F Schiele, P Laeis, PE Reimitz, R Smolnik, W Zierhut, J Tijssen, A Goette

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading